Equitable Mackenzie Bluewater Canadian Growth Balanced
October 31, 2026
Fund Overview
The objective of the segregated fund is to invest in units of the Mackenzie Bluewater Canadian Growth Balanced Fund or a substantially similar fund.
The underlying fund objective is to provide long-term capital growth and income by investing primarily in a well-diversified balanced portfolio of Canadian equity instruments, fixed income and money market securities.
Risk Rating
This fund's risk rating is Low to Medium
As of August 31, 2026
Top 10 Holdings (%)
As of August 31, 2026
Growth of $10,000
As of October 31, 2026
For the period 12/31/2010 through 10/31/2026 with $10,000 CAD investment, The value of the investment would be $17,338
Calendar Return (%)
As of October 31, 2026
| Period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 2.08 | 8.62 | 7.56 | -11.35 | 12.58 | 9.14 | 15.66 | -9.70 | 4.84 | 16.10 |
| Quartile | 4 | 4 | 4 | 4 | 3 | 1 | 1 | 4 | 3 | 1 |
Compound Return (%)
As of October 31, 2026
| Period | 1 mth | 3 mths | 6 mths | 1 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|---|---|
| Fund | 0.35 | 0.69 | 1.91 | -1.79 | 5.87 | 1.38 | 3.83 |
| Quartile | 4 | 2 | 4 | 4 | 4 | 4 | 4 |
Fund Information
| Description | Guarantee Fee | DSC | Heaped NL | Level NL |
|---|---|---|---|---|
| Pivotal Solutions | - | EQU535 | EQU235 | EQU335 |
| Personal Investment Portfolio | - | EQU135 | - | - |
Other Fund Information
Product Availabilty
Pivotal Solutions and Personal Investment Portfolio
Date of Inception:
January 2011
Net Asset Value per Unit:
$17.53 (11/13/2026)
Change: -$0.03 (-0.19%)
Estimated Management
Expense Ratio (MER)†:
3.13%
Fund Category
Canadian Equity Balanced
Portfolio Manager
Mackenzie Financial Corporation
Performance Chart
Summary
For the period 12/31/2010 through 10/31/2026 with $10,000 CAD investment
Total returns performance
73.38%
Last price
$17.34 CAD
as of market close 10/31/2026
Value of $10,000 investment
$17,337.72 CAD